Neuroscience
Dementia Praecox
100%
Positron Emission Tomography
21%
Gray Matter
17%
Placebo
16%
Bipolar Disorder
16%
Fluorine-18
14%
Negative Syndrome
13%
Psychosis
13%
Gene Expression
11%
Positive Syndrome
10%
Anterior Cingulate Cortex
9%
Metabolic Pathway
9%
Antipsychotic
8%
Thalamus
8%
Typical Antipsychotic
8%
Voxel-Based Morphometry
8%
Glutamic Acid
7%
Glutathione
7%
Euphoria
7%
Brain Imaging
7%
Electrical Brain Stimulation
7%
Central Nervous System
6%
Claustrum
6%
Gluten
6%
Cerebral Ventricle
6%
Cognitive Disorders
6%
Nicotinic Acetylcholine Receptor
6%
Nuclear Magnetic Resonance Spectroscopy
6%
Haloperidol
6%
Hippocampus
5%
Olfactory Epithelium
5%
Superior Frontal Gyrus
5%
Magnetic Resonance Imaging
5%
Delusion
5%
Keyphrases
Schizophrenia
71%
Schizophrenic Patients
18%
Cocaine
14%
Healthy Controls
13%
Bipolar Disorder
12%
Placebo
11%
Gray Matter Volume
11%
Gluten Sensitivity
10%
Schizophrenia Symptoms
8%
Patients with Schizophrenia
8%
Nasal Biopsy
8%
Voxel-based Morphometry
8%
Cerebral Glucose Metabolism
7%
Neural Epithelium
7%
Negative Symptoms
7%
People with Schizophrenia
7%
Gray Matter
7%
Positive Symptoms
7%
Deep Brain Stimulation
7%
Human Brain
6%
Celiac Disease
6%
Disease Sensitivity
6%
Traumatic Brain Injury
6%
Major Mental Illness
6%
Olfactory Sensory Neuron
6%
DISC1
6%
Positron Emission Tomography
6%
Antipsychotics
6%
First-episode Psychosis
6%
Cardiovascular Reactivity
5%
Non-smokers
5%
Cognitive Deficits
5%
Brain Regions
5%
Schizoaffective Disorder
5%
Olfactory Epithelium
5%